TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2026 Earnings Call Transcript May 6, 2026
TG Therapeutics, Inc. misses on earnings expectations. Reported EPS is $0.12 EPS, expectations were $0.23.
Operator: Greetings, and welcome to the TG Therapeutics First Quarter Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Jenna Bosco, Chief Communications Officer. Thank you. You may begin.
Jenna Bosco: Thank you....
